high-dose melphalan as a preparative regimen for autohsct in hl and nhl
Published 2 years ago • 143 plays • Length 2:22Download video MP4
Download video MP3
Similar videos
-
4:06
high-dose melphalan increases the mutational load in myeloma cells at relapse
-
2:49
genomic changes induced by high-dose melphalan in myeloma
-
1:59
mutational burden at relapse following exposure to high dose melphalan in multiple myeloma
-
42:12
hla-haploidentical vs matched unrelated donor trans. w posttrans. cyclophosphamide-based prophylaxis
-
1:39
managing early & late relapse after first-line therapy for dlbcl
-
2:26
early relapse: options for rescue
-
2:11
ly.12 & coral: long-term survival in relapsed dlbcl after asct
-
2:40
treatment considerations at first relapse after transplantation
-
2:50
conditioning intensity and genomics: relapse after allogeneic transplant in mds
-
2:33
dli following haplohct ptcy relapse
-
1:17
predictors of early relapse in transplant-eligible mm patients
-
2:15
phase ib/ii trial of siremadlin alone or in combination with dli in high-risk aml post-allosct
-
1:35
how early intervention impacts long-term survival in patients with mf
-
1:59
relapse after stem cell transplant: differences in leukemic cells
-
2:36
leukemia immune evasion in relapse after haploidentical hematopoietic cell transplantation
-
2:04
video 29- transplant day -2 melphalan chemo infusion
-
1:16
dr. green on early relapse in multiple myeloma
-
10:11
early changes in intermediate monocyte distribution correlate with relapse free survival...
-
2:16
the value of the early relapse ebmt score in multiple myeloma